Word

Status

Registered

Status Code

700

Status Date

Tuesday, January 2, 2018

Serial Number

79198170

Registration Number

5366762

Registration Date

Tuesday, January 2, 2018

Mark Type

3

Filing Date

Thursday, August 4, 2016

Published for Opposition

Tuesday, October 17, 2017

Trademark Owner History

EVERIMMUNE -
GUSTAVE ROUSSY TRANSFERT - Original Registrant

Classifications

9 Computer programs for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; recorded computer programs regardless of the medium for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; pre-recorded magnetic, electronic, optical, magneto-optical data media, memory cards, CD-ROMs, digital videodisks featuring information on cancer; pre-recorded optical disks featuring information on cancer; pre-recorded magneto-optical disks featuring information on cancer; pre-recorded magnetic tapes featuring information on cancer; downloadable or non-downloadable software for aiding in the detection, recognition, evaluation, diagnosis and characterization of cancer, for aiding for the treatment and prevention of cancer, for searching for similar cases in databases or archiving systems, and for generating analytical or diagnostic reports; computer programs and software used for the acquisition, visualization, processing, exploitation, annotation, storage, searching, dissemination and printing of all types of medical data, especially of images obtained by a radiographic means by X-ray, scanner, petscan, ultrasonography, magnetic resonance, tomography for the purpose of cancer screening, diagnosis or treatment, in the medical, surgical and health field and in cancer research; apparatus for recording, transmission and reproduction of sound or images; data processing equipment for processing information, computers

5 pharmaceutical products, namely, pharmaceutical preparations, medicines and vaccines for treatment and prevention of cancer

44 Medical services; hospital services; medical analyses namely, medical testing for diagnostic or treatment purposes; medical expertise services namely, medical diagnostic testing, monitoring, reporting and performing a diagnosis of cancer; health services namely, treatment of cancer; medical and surgical services; medical imaging, radiotherapy, brachytherapy and medical dosimetry services for treating cancer; medical diagnosis services namely, analysis and interpretation of images generated by x-ray apparatus, scanner, positron emission tomography (PET) scanner, magnetic resonance imaging scanner, ultrasound scanner; medical information services in the field of the fight against cancer, namely, information on cancer treatment

10 Surgical, medical, dental and veterinary apparatus and instruments namely, x-ray apparatus, scanner, positron emission tomography (PET) scanners, magnetic resonance imaging scanner, ultrasound scanner, radiotherapy treatment apparatus, artificial limbs, eyes and teeth; orthopedic articles namely, orthopedic implants, orthopedic bandages and splints, orthopedic braces; suture material

42 Scientific research services, namely cancer research, medical research services, research and development of new medical products, research in the fields of bacteriology, biology, chemistry; scientific information services in the field of the fight against cancer, clinical research, research and biology laboratories; research for new treatments and pharmaceutical products, vaccines, medicines against cancer

The mark consists of the wording "ever Immune" in black with four incomplete blue and black ovals to the left of the wording "ever". A blue filled black circle dots the letter "I". The color white represents background and is not a feature of the mark.
The color(s) blue and black is/are claimed as a feature of the mark.
"IMMUNE"

Trademark Events

Dec 20, 2016

Assigned To Examiner

Dec 15, 2016

Sn Assigned For Sect 66a Appl From Ib

Dec 20, 2016

New Application Office Supplied Data Entered

Dec 23, 2016

Non-Final Action Written

Dec 24, 2016

Application Filing Receipt Mailed

Dec 24, 2016

Non-Final Action (Ib Refusal) Prepared For Review

Dec 29, 2016

Non-Final Action (Ib Refusal) Withdrawn For Review

Dec 30, 2016

Non-Final Action Written

Dec 31, 2016

Non-Final Action (Ib Refusal) Prepared For Review

Jan 13, 2017

Refusal Processed By Mpu

Jul 5, 2017

Teas Response To Office Action Received

Jan 13, 2017

Non-Final Action Mailed - Refusal Sent To Ib

Feb 3, 2017

Refusal Processed By Ib

Sep 1, 2017

Examiners Amendment E-Mailed

Jul 5, 2017

Teas/Email Correspondence Entered

Jul 5, 2017

Correspondence Received In Law Office

Jul 22, 2017

Approved For Pub - Principal Register

Jul 23, 2017

Previous Allowance Count Withdrawn

Aug 22, 2017

Non-Final Action Written

Aug 22, 2017

Non-Final Action E-Mailed

Aug 22, 2017

Notification Of Non-Final Action E-Mailed

Sep 1, 2017

Examiners Amendment -Written

Sep 1, 2017

Examiner's Amendment Entered

Sep 1, 2017

Notification Of Examiners Amendment E-Mailed

Apr 2, 2018

Final Disposition Notice Created, To Be Sent To Ib

Sep 1, 2017

Approved For Pub - Principal Register

Sep 27, 2017

Notification Of Notice Of Publication E-Mailed

Oct 4, 2017

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Oct 4, 2017

Notification Of Possible Opposition Sent To Ib

Oct 17, 2017

Published For Opposition

Oct 17, 2017

Official Gazette Publication Confirmation E-Mailed

Oct 21, 2017

Notification Processed By Ib

Jan 2, 2018

Registered-Principal Register

May 22, 2022

Change Of Owner Received From Ib

Apr 12, 2018

Final Disposition Processed

Apr 12, 2018

Final Disposition Notice Sent To Ib

May 19, 2018

Final Decision Transaction Processed By Ib

Jan 23, 2020

New Representative At Ib Received

Feb 6, 2020

Teas Change Of Correspondence Received

Jul 4, 2022

Correction Transaction Received From Ib

Oct 7, 2022

Correction From Ib Entered - No Review Required

Apr 13, 2024

New Representative At Ib Received

Jan 2, 2023

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed